Project Grant F32AI191534
- The National Science Foundation (NSF) awarded a 5-year, $977,779 Project Grant under the Biological Sciences (CFDA 47.074) program to the University of California, Santa Barbara (UCSB) to investigate how climate change and land use shifts may impact the synchronization between mosquito vectors and bird hosts, and the implications for West Nile Virus transmission. The research will leverage a combination of modeling, causal inference, citizen science, and field data collection to understand how...
- This Project Grant award of $392,500.00 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) supports a research program at Arizona State University (ASU) focused on improving the understanding of cross-species viral transmission from wild mammals to humans. The key objectives of the five-year project are to: 1) develop automated tools to curate and maintain up-to-date taxonomic data on mammal and virus species, 2) test...
- This Project Grant award of $651,084, made by the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074), supports research to determine how microbes influence the response of their mosquito host to climate change, with a focus on the impacts on Hawaiian honeycreepers, an endangered bird species. The research aims to: Clarify the landscape-scale population dynamics of the mosquito vector Culex quinquefasciatus and its microbiome across an elevational gradient in Hawaii....
- The National Science Foundation (NSF) awarded a 3-year, $300,000 Project Grant under the Mathematical and Physical Sciences (CFDA 47.049) federal grant program to the Trustees of Indiana University, doing business as Indiana University. The grant will support the development and validation of modeling tools and ensembling approaches to generate 1- to 4-week ahead forecasts of the relative abundance of disease-carrying mosquito species in the United States, such as Aedes aegypti and Aedes...
- This Project Grant award from the National Science Foundation (NSF) Division of Mathematical Sciences, CFDA 47.049 Mathematical and Physical Sciences, provides $265,000 in funding to the University of Missouri at Kansas City (UMKC) from September 1, 2023 to August 31, 2026. The project aims to enhance mathematical models to investigate the influences of climate change on zoonotic disease transmission, or the transmission of infectious diseases from animals to humans. The research team will use...
- This $611,861 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to characterize chromosomal rearrangements in the Aedes aegypti mosquito, which transmits diseases like dengue and Zika fever. The 5-year project, commencing on September 1, 2025, aims to determine if these rearrangements are subspecies-specific, associated with ecological factors in Africa, and involved in mosquito...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support the development of a novel mouse model that co-engrafts a functional human immune system and human skin organoids. The goal is to create a more accurate animal model to study the human cutaneous responses to arthropod-borne viruses like Zika, dengue, and tick-borne viruses. This $449,625 award to Trustees of Boston...
- This National Science Foundation (NSF) Project Grant award, funded under the Social, Behavioral, and Economic Sciences program (CFDA 47.075), aims to investigate the role of human behavior in the dynamics of mosquito-borne diseases such as dengue and Zika. The $100,000 grant, awarded to North Carolina State University (NC State), will support a multidisciplinary research project to understand how individual decision-making around mosquito prevention behaviors impacts disease transmission. The...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) is focused on understanding the underlying mechanisms that allow bats to host viruses that cause high mortality in humans, such as rabies, Hendra, Nipah, Ebola, and SARS. The $455,692 award will enable experimental evolution studies on vesicular stomatitis virus (VSV) in bat cell lines to test theoretical predictions about how...
- This Project Grant award of $422,814 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to develop an adversarial machine learning approach to predict the risk of animal viruses spilling over into humans. The project will (i) consider evolutionary variants to assess spillover risk beyond a "static" viral sequence, (ii) characterize and explain the risk prediction for a given virus, and...
PREDICTING JAPANESE ENCEPHALITIS SPILLOVER RISK IN THE UNITED STATES - JAPANESE ENCEPHALITIS VIRUS (JEV) IS A MOSQUITO-BORNE VIRUS THAT IS A MAJOR CAUSE OF HUMAN VIRAL ENCEPHALITIS IN ASIA, WITH UPWARDS OF 65,000 CASES OCCURRING ANNUALLY. JEV IS FOUND IN A TRANSMISSION CYCLE BETWEEN WATERBIRDS, SWINE, CULEX SPP. MOSQUITOES AND INCIDENTAL HOSTS OF PEOPLE AND ANIMALS. JEV HAS RECENTLY BEGUN TO SPREAD TO NEW AREAS SUCH AS AUSTRALIA. JEV RISK IS OF GREAT IMPORTANCE GIVEN THE INCURSION OF VECTOR-BORNE DISEASES LIKE WEST NILE VIRUS, ZIKA VIRUS, AND CHIKUNGUNYA VIRUS INTO NEW REGIONS. ACROSS THE GLOBE TEMPERATURE IS INCREASING AND MOSQUITO-BORNE DISEASES ARE UNIQUELY RESPONSIVE TO SUCH INCREASES. AS A RESULT, ASSESSING TRANSMISSION OF VECTOR-BORNE DISEASES ACROSS TEMPERATURES IS CRUCIAL. THE INTERSECTION OF COMPETENT VECTORS, SUSCEPTIBLE HOSTS, AND SUITABLE ENVIRONMENTS HAS BEEN LINKED TO EMERGING VECTOR-BORNE DISEASES. PREDICTING THE LIKELIHOOD OF CONTACT AND TRANSMISSION BETWEEN HOSTS FOUND IN THE US IS KEY TO ESTIMATING JEV RISK. TO ADDRESS THIS CRITICAL GAP, I SEEK TO DEVELOP A SPILLOVER MODEL OF JEV RISK IN THE US. RESEARCHERS DEVELOPED A FRAMEWORK FOR MODELING R0 BASED ON EMPIRICAL DATA FROM MOSQUITO LIFE HISTORY EXPERIMENTS TO ESTIMATE THE SUITABILITY FOR PATHOGEN TRANSMISSION ACROSS TEMPERATURES. SUCH MODELS EXIST FOR NUMEROUS MOSQUITO-BORNE DISEASES, BUT DATA ON JEV TRANSMISSION ACROSS TEMPERATURE IS LACKING. LIKEWISE, SPILLOVER MODELS THAT ATTEMPT TO INCORPORATE THE FULL SUITE OF ECOLOGICAL AND DEMOGRAPHIC DRIVERS OF TRANSMISSION OF ZOONOTIC VECTOR-BORNE DISEASES HAVE BEEN DEVELOPED FOR OTHER PATHOGENS, YET DESPITE ITS SPILLOVER POTENTIAL, JEV HAS YET TO BE INVESTIGATED IN THIS HOLISTIC FRAMEWORK. IN THIS PROPOSAL I WILL ADDRESS THESE GAPS THROUGH DISTINCT BUT INTERCONNECTED AIMS, LEVERAGING VECTOR BIOLOGY AND COMPUTATIONAL MODELING TO: 1) EXPERIMENTALLY MEASURE THE EFFECT OF TEMPERATURE ON JEV INFECTION AND TRANSMISSION IN MULTIPLE US VECTOR SPECIES AND VIRUS GENOTYPES, 2) EVALUATE TEMPERATURE SUITABILITY FOR JEV TRANSMISSION ACROSS THE US, 3) DEVELOP MECHANISTIC SPILLOVER MODELS TO PREDICT JEV RISK USING AMPLIFYING AND RESERVOIR HOST DISTRIBUTIONS, ALONG WITH OTHER CLIMATIC AND ECOLOGICAL INFORMATION, ACROSS THE US. IN SUMMARY, I PROPOSE TO DEVELOP A MECHANISTIC MODEL OF JEV SPILLOVER IN THE US, UTILIZING A ONE HEALTH APPROACH, ACCOUNTING FOR VECTOR, AMPLIFYING, RESERVOIR, AND INCIDENTAL HOSTS FOUND IN THE TRANSMISSION CYCLE OF JEV. THE EMERGENCE OF ZOONOTIC DISEASES HAS INCREASED. WE CAN PREPARE FOR THE EMERGENCE OF FUTURE PATHOGENS BY SYNTHESIZING DATA ACROSS MULTIPLE SCALES TO GAIN A HOLISTIC UNDERSTANDING OF TRANSMISSION DYNAMICS BY INCORPORATING CLIMATIC AND ZOONOTIC DRIVERS. THE PROPOSED RESEARCH WILL EXPAND OUR UNDERSTANDING BY PROVIDING NOVEL EMPIRICAL DATA NECESSARY TO PREDICT JEV RISK UNDER DIFFERENT TEMPERATURE SCENARIOS AND IDENTIFY HIGH-RISK AREAS IN THE US. OVERALL, THIS PROJECT HAS THE POTENTIAL TO CONTRIBUTE TO NEW INSIGHTS INTO THE TRANSMISSION DYNAMICS OF ZOONOTIC DISEASES AND THE RISK OF SPILLOVER.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $75.1k | 9/10/25 |